Candel Therapeutics, Inc. Common Stock CADL
$13.13
+6.32%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-88,531,000
- Net Margin
- —
- Return on Equity
- -70.19%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 7.97
- Price / Sales
- —
Over the trailing twelve months, Candel Therapeutics, Inc. Common Stock generated revenue of — and net income of $-88,531,000.
Key Stats
- Last Close
- $13.13
- Market Cap
- $1.00 billion
- 52-Week Range
- $4.35 – $13.82
- Average Volume
- 1.30 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.